Home >> Secom > Suplimente Nutritive >> AHCC 30cps SECOM

 

Descriere produs:

 AHCC 30cps SECOM 

AHCC 30cps SECOM 

 

 

 

 

AHCC  (Active Hexose Correlated Compound) este un produs obtinut din miceliul mai multor specii de ciuperci basidiomicete folosite în medicina traditionala japoneza. Ciupercile provin din culturi ecologice japoneze si sunt cultivate în extract de tarâte de orez. Procesul de fabricatie a AHCC  a fost dezvoltat si brevetat de Amino-Up Chemical Company din Sapporo, Japonia. Acest proces, extrem de complex, se desfasoara în conditii de laborator si include cultura amestecului de ciuperci într-un mediu lichid, modificarea enzimatica obtinuta prin fermentare, apoi purificarea si uscarea prin refrigerare. Oligozaharidele din AHCC  au masa moleculara sub 5.000 Daltoni ceea ce le asigura bio-absorbtia intestinala optima în cazul administrarii orale. În plus, AHCC  contine GI-zaharide, un tip de glicozide cu greutatea moleculara sub 1.000 Daltoni, usor digerabile, puternic imunostimulatoare. AHCC  este obiectul a peste 200 de studii publicate începând cu anul 1986 si este folosit în peste 700 de spitale din Japonia. Începând din anul 1994 se organizeaza anual la Sapporo Simpozionul Asociatiei pentru Cercetarea AHCC  la care participa peste 300 de medici si cercetatori.

 

Actiuni: 

- regleaza raportul Th1/Th2 în favoarea limfocitelor Th1 care stimuleaza producerea de:

- gamma-interferon: imunostimulator, antimicrobian, antiparazitar, antiviral, antiproliferativ (creste activitatea celulelor NK - natural ucigase, cu pâna la 300%, activeaza macrofagele, induce sinteza oxidului nitric)

- factor de necroza tumorala (TNFá): declanseaza apoptoza celulelor tumorale

- interleukine IL-1, IL-2 si IL-12: reduc producerea factorului tumoral de crestere TGF-ß, potenteaza activitatea NK si genereaza celule LAK (celule activate de limfokine) care lezeaza celulele infectate viral sau maligne

- activeaza celulele dendritice care moduleaza raspunsul imunitar primar

- creste capacitatea de adaptare a organismului la conditii de stres prelungit:

- reduce depresia imunitara celulara cauzata de excesul de cortizol, hiperglicemia cauzata de secretia excesiva de adrenalina

- reduce actiunea enzimei ornitin decarboxilaza crescuta în stari preneoplazice

 

Recomandat în:

- cancer hepatic, gastric, colo-rectal, pancreatic, pulmonar, oro-faringian, mamar, tiroidian, ovarian, testicular, prostatic, renal, mielom, rabdomiosarcom

- chimioterapie: asocierea chimioterapiei cu AHCC  stimuleaza actiunea celulelor NK (tratamentele chimioterapice inhiba celulele NK cu pâna la 75%), reduce tumorile primare cu pâna la 20%, metastazarea cu pâna la 30%, creste actiunea macrofagelor cu pâna la 96%; reduce efectele secundare: greata, caderea parului, oboseala, diminuarea apetitului, toxicitatea hepatica, mielo supresia (anemie, trombocitopenie, neutropenie, leucopenie), scaderea ponderala, infectiile oportuniste

- hepatite cronice virale B, C sau etanolice: îmbunatateste structura si functiile hepatice, reduce încarcarea virala, progresia cirozei si recurenta post-chirurgicala a carcinomului hepatocelular

- infectii cu HIV, virusul herpetic, gripal, Klebsiella pneumoniae, Candida albicans, Pseudomonas aeruginosa, Staphylococcus aureus, toxine din mediu; diabet zaharat tip II; sclerodermie, eczeme, alergii, lupus sistemic eritematos

 

 

 
 

English:

SECOM 30cps 30cps SECOM AHCC AHCC AHCC (Active Hexose Correlated Compound) is a product obtained from several species of mushroom mycelium basidiomicete used in Japanese traditional medicine. Japanese mushrooms from organic crops and are grown in rice bran extract. Process madeIE AHCC was developed and patented by Amino Up Chemical Company in Sapporo, Japan. This process is extremely complex and takes place in laboratory conditions and includes culture mushroom mixture in a liquid medium, modified enzyme obtained by fermentation, and purification and drying by freezing. Oligosaccharides have molecular weight of AHCC in 5000Daltons which ensure their bio for optimal intestinal absorption of oral administration. In addition, AHCC contains GI-saccharide, a type of glycosides with molecular weight below 1000 Dalton, easily digestible, highly immunostimulatory. AHCC is the subject of over 200 studies published since 1986 and is used in over 700 hospitals in Japan.Since 1994 is held annually in Sapporo AHCC Research Association Symposium to over 300 attending physicians and researchers. Actions - regulate Th1/Th2 ratio in favor of TH1 lymphocytes, which stimulates the production of: - gamma-interferon: immunostimulating, antimicrobial, antiparasitic, antiviral, antiproliferative (note increaseivitatea NK cells - natural killer, with up to 300%, activates macrophages, induces nitric oxide synthesis) - tumor necrosis factor (TNFá) triggers apoptosis of tumor cells - interleukins IL-1, IL-2 and IL-12: reduced production tumor growth factor TGF-ß, enhances NK activity and generates Lak cells (cells activated limfokine), which damages theLele viral infection or malignant - which activates dendritic cells modulates the primary immune response - increasing adaptability of the body to prolonged stress conditions: - reduce the cellular immune depression caused by excess cortisol, hyperglycemia caused by excessive secretion of adrenaline - reduce the action of the enzyme ornithine decarboxylase increased in preneoplastic statess Recommended: - liver cancer, gastric cancer, colo-rectal cancer, pancreatic, lung, oral-pharyngeal, breast, thyroid, ovary, testis, prostate, kidney, myeloma, rhabdomyosarcoma - chemotherapy: combination chemotherapy with AHCC stimulates NK cell action (treatment NK cells inhibit chemotherapy by 75%) primary tumors reduced to 20%, metastazarea up to 30%, increases the action of macrophages with up to 96%, reduce side effects: nausea, hair loss, fatigue, decreased appetite, liver toxicity, mielo suppression (anemia, thrombocytopenia, neutropenia, leukopenia), weight loss, opportunistic infections - chronic viral hepatitis B, C or ethanol: structure and function improves liverreduce the viral load, progression of cirrhosis and recurrent post-surgical hepatocellular carcinoma - HIV, herpes, influenza, Klebsiella pneumoniae, Candida albicans, Pseudomonas aeruginosa, Staphylococcus aureus toxins in the environment, type II diabetes, scleroderma, eczema, allergies , systemic lupus erythematosus